InvestorsHub Logo
Followers 38
Posts 2533
Boards Moderated 0
Alias Born 02/28/2018

Re: Giovanni post# 4242

Tuesday, 04/12/2022 8:38:51 AM

Tuesday, April 12, 2022 8:38:51 AM

Post# of 4689
LOL....So you didn't even read the article that you posted twice.
Did you read the financials? Just kidding I dont care....
Boston globe hahahahaha

MRMD doesn't care either, especially about the Boston globe news rag.... neither do actual customers

2022 FINANCIAL TARGETS
Considering MariMed’s strategic plan to drive long-term growth, recent acquisitions, license wins, and current industry dynamics, the Company has set the following financial targets for the full fiscal year 2022:

Revenue of $145 to 150 million.
Adjusted EBITDA of $47 to $52 million.
CAPEX spend of approximately $25 million
“After setting financial targets in 2021 for the first time, and subsequently raising and beating them, I am pleased to announce very strong financial growth targets for 2022,” said Jon Levine, Chief Financial Officer of MariMed. “Our strict financial discipline combined with our outstanding operations give us confidence we will meet or beat our full year financial guidance once again in 2022.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRMD News